Literature DB >> 6819484

Human melanoma cell lines: morphology, growth, and alpha-mannosidase characteristics.

J Siracký, M Blasko, J Borovanský, J Kovarík, J Svec, M Vrba.   

Abstract

Four human melanoma cell lines were characterized by evaluation of the morphology, ultrastructure, cytogenetics, plating efficiency, agar colony formation and alpha-mannosidase values. Biochemical studies demonstrate that all studied lines produced alpha-mannosidase even under condition of long-term in vitro growth. All respective lines were characterized by a great variations in biological markers studied and very few reliable comparisons could be obtained as regards the proliferation activity and capacity, cellular composition and clonogenic potential as well. Due to cellular selections during long-term in vitro cultivation, the range for using these experimental systems as models for the study of biology of human malignant melanoma seems to be rather limited.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819484

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

1.  Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.

Authors:  J Bizik; A Lizonová; R W Stephens; M Grófová; A Vaheri
Journal:  Cell Regul       Date:  1990-11

Review 2.  Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma.

Authors:  Manisha Miller; Lynn Schoenfield; Mohamed Abdel-Rahman; Colleen M Cebulla
Journal:  Ocul Oncol Pathol       Date:  2021-04-22

3.  Learning from Embryogenesis-A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development.

Authors:  Lisa Linck-Paulus; Lisa Lämmerhirt; Daniel Völler; Katharina Meyer; Julia C Engelmann; Rainer Spang; Norbert Eichner; Gunter Meister; Silke Kuphal; Anja Katrin Bosserhoff
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.